Examkin

Soru

Zorluk: Çok zorEnd-of-Life and Palliative Care

Match each advanced palliative clinical scenario with the most appropriate, highly specific next step in management.

  • A 75-year-old hospice patient with terminal pancreatic cancer develops refractory nausea, severe colicky abdominal pain, and obstipation. She strongly refuses a venting gastrostomy tube.Initiate somatostatin analog therapy
  • A 62-year-old with metastatic melanoma on continuous intravenous hydromorphone develops escalating diffuse pain, severe tactile allodynia, and spontaneous myoclonus following recent dose escalations.Rotate to methadone or initiate NMDA-receptor antagonist therapy
  • A 58-year-old with advanced breast cancer develops severe right upper quadrant pain radiating to the right shoulder due to massive hepatic tumor burden. Baseline opioids provide minimal relief.Initiate targeted corticosteroid therapy
  • An 82-year-old comatose dying patient with a documented history of severe narrow-angle glaucoma develops loud, gurgling respirations due to pooling oropharyngeal secretions.Perform non-pharmacologic positional drainage

Cevap

1) Malignant bowel obstruction matched with somatostatin analog therapy; 2) Opioid-induced hyperalgesia matched with methadone rotation/NMDA antagonism; 3) Hepatic capsular stretch pain matched with targeted corticosteroid therapy; 4) Terminal secretions with a glaucoma contraindication matched with non-pharmacologic positional drainage.
Each correct match directly addresses the underlying pathophysiological mechanism of the palliative symptom while avoiding patient-specific contraindications. Malignant bowel obstruction requires secretory reduction via somatostatin analogs. Opioid-induced hyperalgesia necessitates receptor rotation (methadone) or NMDA antagonism. Hepatic capsular stretch responds to the anti-inflammatory effects of corticosteroids. Terminal secretions in the setting of narrow-angle glaucoma must be managed non-pharmacologically to avoid anticholinergic-induced acute angle-closure crisis.

Adım Adım Çözüm

1
Analyze the patient with pancreatic cancer and signs of bowel obstruction.
Identifies inoperable malignant bowel obstruction (MBO) requiring medical management.
Because the patient refuses venting, octreotide is required to directly reduce GI secretions and splanchnic perfusion.
2
Evaluate the patient with melanoma experiencing allodynia and myoclonus after opioid escalation.
Diagnoses opioid-induced hyperalgesia (OIH).
Escalating opioids paradoxically worsens OIH due to central sensitization; treatment requires rotation to methadone or adding ketamine (NMDA antagonists).
3
Assess the patient with breast cancer and right upper quadrant pain radiating to the shoulder.
Identifies pain secondary to hepatic capsular stretch (Glisson's capsule).
Opioids are insufficient for capsular tension; corticosteroids effectively reduce peritumoral edema and relieve visceral stretching.
4
Review the comatose patient with noisy breathing and a history of narrow-angle glaucoma.
Recognizes 'death rattle' in a patient where anticholinergics are contraindicated.
Standard anticholinergics can precipitate acute angle-closure glaucoma; lateral repositioning is the safest and most appropriate definitive step.

Anahtar Kavram

Advanced symptom management in end-of-life care requires tailoring highly specific pharmacologic interventions (e.g., octreotide, methadone, dexamethasone) to the precise etiology of the symptom, while substituting non-pharmacologic measures when absolute contraindications exist.
Bu soruyu puanla

Konular

End-of-Life and Palliative Care

Bu konudan daha fazla soru